Previous Close | 0.9000 |
Open | 0.8000 |
Bid | 0.0000 |
Ask | 0.7000 |
Strike | 10.00 |
Expire Date | 2025-01-17 |
Day's Range | 0.8000 - 0.9000 |
Contract Range | N/A |
Volume | |
Open Interest | 210 |
Merck (MRK) exercises the option that will convert the collaboration deal with partner Orion for prostate cancer candidate opevesostat into a license agreement.
Here, we discuss some reasons why buying Bioventus (BVS) stock now may turn out to be a prudent move.
J&J (JNJ) seeks expanded use of its HIV-1 therapy, Prezcobix, for younger kids in the United States and Europe.